Elsevier

Life Sciences

Volume 68, Issue 8, 12 January 2001, Pages 913-920
Life Sciences

Original articles
Effects of nitric oxide on matrix metalloproteinase-2 production by rheumatoid synovial cells

https://doi.org/10.1016/S0024-3205(00)00998-XGet rights and content

Abstract

Nitric oxide (NO) is a multifunctional messenger molecule generated from L-arginine by a family of enzymes, including nitric oxide synthase (NOS). This study was performed to examine whether NO modulates the production of matrix metalloproteinases (MMPs), which degrade all components of extracellular matrix (ECM), in rheumatoid synovial cells. We investigated the effects of exogenously generated NO by a NO donor, S-nitroso-N-acetyl-DL-penicillamine (SNAP), on the MMPs production by rheumatoid synovial cells. Culture media conditioned by SNAP-treated synovial cells were examined by gelatin zymography and immunoblot analysis. Incubation of synovial cells with SNAP resulted in gelatinase A production in a dose-dependent fashion. Furthermore, RT-PCR analysis demonstrated that MMP-2 mRNA expression was induced in SNAP-treated synovial cells. In contrast, SNAP did not influence the production of TIMP-1 and TIMP-2, which preferentially inhibit MMP-2, by rheumatoid synovial cells. Our data indicate that NO could modulate MMP production by rheumatoid synovial cells and therefore contribute to ECM degradation of articular components in RA.

References (0)

Cited by (45)

  • Pathogenesis of Osteoarthritis

    2016, Kelley and Firestein's Textbook of Rheumatology: Volumes 1-2, Tenth Edition
  • Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration

    2012, Molecular Aspects of Medicine
    Citation Excerpt :

    Accordingly, dysregulated turnover of ECM is a major mechanism of disease pathogenesis in many tissue sites, including renal disease, atherosclerosis, lung disease and others (Aumailley and Gayraud, 1998; Belkhiri et al., 1997; Jacot et al., 1996; Kuzuya and Iguchi, 2003; Ohbayashi, 2002; Peten et al., 1992; Ries and Petrides, 1995; Schroen and Brinckerhoff, 1996). The capacity of oxidant injury to regulate production of ECM, especially to modulate the expression and activity of MMP-2 has been documented in different cell types (Ha and Lee, 2000; Hirai et al., 2001; Kinnula et al., 1998; Lee et al., 2003; Mattana et al., 1999). Unfortunately, minimal information is available concerning normal turnover in healthy BrM or dysregulated turnover in AMD eyes.

  • Pathogenesis of Osteoarthritis

    2012, Kelley's Textbook of Rheumatology: Volume 1-2, Ninth Edition
  • Differentiation of human osteosarcoma cells by isolated phlorotannins is subtly linked to COX-2, iNOS, MMPs, and MAPK signaling: Implication for chronic articular disease

    2009, Chemico-Biological Interactions
    Citation Excerpt :

    These cytokines stimulate connective tissue cells and articular chondrocytes, and deduce a series of shared phosphorylation events within the cells that prompt transcriptional induction of MMPs. Also, it is likely that IL-1β upregulates other mediators, such as NO which may regulate MMPs by synovial cells and thus contributes to ECM degradation of articular components [26,27]. NO is an important messenger molecule functioning in vascular regulation, host immune defence, neurotransmission and other systems [28].

View all citing articles on Scopus
View full text